QA102 Phase II Study in Subjects With Dry AMD
Public ClinicalTrials.gov record NCT05536752. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Masked, Randomized, Placebo-Controlled, Dose-Response Study Assessing the Safety and Efficacy of QA102 in Subjects With Dry Age-Related Macular Degeneration (AMD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 2, double-masked, randomized, placebo-controlled, dose-response study. The primary objective of the study is to evaluate the efficacy of QA102 oral capsules on the development of soft drusen, visual acuity (VA), and geographic atrophy (GA) or choroidal neovascularization (CNV) or the progression of GA in subjects with intermediate to advanced dry AMD.
Study identification
- NCT ID
- NCT05536752
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 22, 2022 (Actual)
- Primary completion
- Nov 12, 2024 (Actual)
- Completion
- Nov 12, 2024 (Actual)
- Last update posted
- Oct 1, 2026
2022 – 2024
United States locations
- U.S. sites
- 29
- U.S. states
- 15
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Associated Retina Consultants | Phoenix | Arizona | 85021 | — |
| Northern California Retina Vitreous Associates Medical Group | Mountain View | California | 94040 | — |
| California Eye Specialists Medical Group | Pasadena | California | 91107 | — |
| California Eye Specialists Medical Group | Redlands | California | 91107 | — |
| Retina Consultants of Southern Colorado, P.C. | Colorado Springs | Colorado | 80909 | — |
| Advanced Research | Deerfield Beach | Florida | 33064 | — |
| National Ophthalmic Research Institute | Fort Myers | Florida | 33912 | — |
| MedEye Associates | Miami | Florida | 33143 | — |
| Retina Specialty Institute | Pensacola | Florida | 32503 | — |
| Eye Associates of Pinellas | Pinellas Park | Florida | 33782 | — |
| Sarasota Retina Institute | Sarasota | Florida | 34239 | — |
| Vitreous and Retina Consultants | Winter Haven | Florida | 33880 | — |
| Marietta Eye Clinic | Marietta | Georgia | 30060 | — |
| University Retina and Macula Associates | Oak Forest | Illinois | 60452 | — |
| Northeast Louisiana dba Haik Humble Eye Center | West Monroe | Louisiana | 71291 | — |
| The Retina Care Center | Baltimore | Maryland | 21209 | — |
| Cumberland Valley Retina Consultants | Hagerstown | Maryland | 21740 | — |
| Mid Atlantic Retina Specialists | Hagerstown | Maryland | 21740 | — |
| Vitreo-Retinal Associates, P.C. | Worcester | Massachusetts | 01605 | — |
| Retina Research Institute | St Louis | Missouri | 63144 | — |
| Velocity Clinical Research | Cincinnati | Ohio | 45202 | — |
| Verum Research, LLC | Eugene | Oregon | 97401 | — |
| Erie Retina Research | Erie | Pennsylvania | 16507 | — |
| Retina Research Institute of Texas | Abilene | Texas | 79606 | — |
| Austin Research Center for Retina | Austin | Texas | 78705 | — |
| AXIS Clinicals LLC / Retina of North Texas | Dallas | Texas | 75243 | — |
| Texas Retina Associates - Plano | Plano | Texas | 75075 | — |
| San Antonio Eye Center | San Antonio | Texas | 78215 | — |
| Rocky Mountain Retina Consultants | Salt Lake City | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05536752, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 1, 2026 · Synced Nov 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05536752 live on ClinicalTrials.gov.